Skadden advises life sciences and health care clients on their most complex legal and regulatory issues across multiple disciplines, including Food and Drug Administration (FDA) regulatory counseling and enforcement defense; government and internal investigations; compliance program design and implementation; litigation and dispute resolution; complex corporate transactions; and the acquisition, enforcement and commercialization of intellectual property and technology assets. Companies and investors across the industry rely on the sector-specific insights of our life sciences and health care attorneys, who work as an integrated team and collaborate to help clients realize scientific innovations as they navigate an ever-evolving landscape.

Skadden is consistently ranked as a leading firm for Healthcare in Chambers USA and for Life Sciences by The Legal 500 U.S. We have been recognized among the top firms for Health Care and FDA Law by Best Lawyers Best Law Firms. In 2022, Skadden was named M&A Firm of the Year and received the award for Impact Deal of the Year from LMG Life Sciences, and was cited as a leading firm for M&A within the life sciences industry in the publication’s rankings. We also received the Healthcare, Pharma & Biotech Deal of the Year (Large Cap) award from The Deal in 2021.